Cargando…
Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study
OBJECTIVES: Anosmia is a common debilitating symptom of the novel coronavirus disease 2019 (COVID-19). Currently, there is no satisfactory treatment of anosmia. Therefore, this study was conducted to evaluate the therapeutic effect of nasal betamethasone drops in the recovery of olfaction in COVID-1...
Autores principales: | Rashid, Rasheed Ali, Zgair, Atheer, Al-Ani, Raid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024226/ https://www.ncbi.nlm.nih.gov/pubmed/33839489 http://dx.doi.org/10.1016/j.amjoto.2021.103033 |
Ejemplares similares
-
Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq
por: Al-Ani, Raid M., et al.
Publicado: (2021) -
Prevalence of Anosmia and Ageusia in Patients with COVID-19 at a Primary Health Center, Doha, Qatar
por: Al-Ani, Raid M., et al.
Publicado: (2020) -
Parosmia Due to COVID-19 Disease: A 268 Case Series
por: Rashid, Rasheed Ali, et al.
Publicado: (2021) -
Commentary on the Letter to the Editor regarding "Dysphonia in COVID-19 patients: Direct or indirect symptom?
por: Al-Ani, Raid M., et al.
Publicado: (2022) -
Prevalence of General and Otorhinolaryngological Symptoms Post-COVID-19 Regarding the Time of Presentation
por: Al-Ani, Raid M., et al.
Publicado: (2021)